Core Viewpoint - Jiangsu Tiannai Technology Co., Ltd. has announced the cancellation of 30,592 shares of unvested restricted stock as part of its 2022 Restricted Stock Incentive Plan, which will not materially affect the company's financial status or operational results [1][9]. Summary by Sections Company Stock Incentive Plan - The company held its second board meeting on June 24, 2022, where it approved the 2022 Restricted Stock Incentive Plan and related management measures [2]. - The company’s supervisory board also approved the plan and the list of initial grant recipients [3]. - The plan was publicly disclosed on June 25, 2022, and no objections were raised during the internal announcement period [4]. Adjustments and Approvals - On July 15, 2022, the company’s first extraordinary general meeting approved the incentive plan, granting the board authority to determine the grant date and manage related matters [5]. - The board and supervisory board meetings on July 16, 2022, confirmed the first grant of restricted stock to the incentive recipients [6]. - On July 13, 2023, the board approved adjustments to the grant price and the total number of unvested restricted stocks [7]. Cancellation of Restricted Stocks - The board meeting on August 29, 2023, approved the cancellation of certain restricted stocks that did not meet vesting conditions [8]. - The total number of restricted stocks canceled amounts to 30,592 shares due to various reasons, including non-vesting conditions [9]. Impact and Legal Opinions - The cancellation of restricted stocks is not expected to impact the company's financial condition or management stability [9]. - The board's compensation and assessment committee confirmed that the cancellation complies with relevant laws and regulations [10].

Group 1 - The core viewpoint of the article is that Hangzhou Aotai Biotechnology Co., Ltd. has conducted a review of the list of incentive objects for its 2024 restricted stock incentive plan and has confirmed their eligibility according to relevant laws and regulations [1][2] - The incentive objects do not include independent directors, supervisors, shareholders holding more than 5% of the company's shares, actual controllers and their immediate family members, or foreign employees [1][2] - The list of incentive objects for the plan is consistent with the list approved at the company's second extraordinary general meeting in 2024 [1][2] Group 2 - The incentive objects meet the qualifications stipulated by the Company Law, Securities Law, and other relevant regulations, confirming their legal and effective status as incentive recipients [2] - The reserved grant date for the incentive plan is set for August 29, 2025, with a grant price of 26.2993 yuan per share for 188,000 restricted shares to be awarded to 41 eligible incentive objects [2]

Core Points - The company has announced the reserved grant of 188,000 restricted stocks under the 2024 Restricted Stock Incentive Plan, with a grant date set for August 29, 2025 [1][2][16] - The grant price for the restricted stocks has been adjusted from 29.24 yuan per share to 26.2993 yuan per share [5][16] - The incentive plan aims to enhance employee cohesion and operational efficiency, potentially leading to improved business performance [18] Summary by Sections Incentive Plan Overview - The 2024 Restricted Stock Incentive Plan has been approved, and the reserved grant conditions have been met [2][16] - A total of 41 individuals will receive the reserved stocks, which represent approximately 0.24% of the company's total share capital [11][16] Grant Conditions and Procedures - The decision-making process for the stock grant has been completed, including necessary disclosures and approvals from the board and supervisory committee [3][4][16] - The company has confirmed that no disqualifying conditions exist for the incentive recipients, ensuring compliance with relevant laws and regulations [6][16] Performance Metrics - The performance assessment for the incentive plan will be conducted over two fiscal years, with specific revenue and product registration targets set for each vesting period [12][15] - The first vesting period requires a revenue target of 1.05 billion yuan, while the second period requires a target of 1.26 billion yuan [12] Accounting and Financial Impact - The fair value of the restricted stocks will be calculated using the Black-Scholes model, and the associated costs will be amortized over the vesting period [18] - The implementation of the incentive plan is expected to have a positive impact on the company's operational performance and internal value [18]

Core Viewpoint - The company has adjusted the grant price of its 2024 restricted stock incentive plan from 29.24 CNY per share to 26.2993 CNY per share due to the implementation of its profit distribution plan [1][5][6] Group 1: Adjustment Details - The adjustment of the grant price was approved by the company's board and supervisory board during their respective meetings [1][2] - The adjustment was made in accordance with the company's 2024 restricted stock incentive plan and the authorization from the second extraordinary general meeting of shareholders [1][5] - The adjusted grant price reflects the cash dividends distributed to shareholders, calculated as follows: P = P0 - V, where P0 is the original grant price and V is the cash dividend per share [4][5] Group 2: Financial Impact - The adjustment of the grant price is not expected to have a substantial impact on the company's financial condition or operating results [5][6] - The adjustment will not affect the stability of the management team or the continued implementation of the incentive plan [5][6] Group 3: Opinions from Supervisory and Compensation Committees - The supervisory board agrees that the adjustment complies with relevant laws and regulations and does not harm the interests of the company and all shareholders [5][6] - The compensation and assessment committee of the board also supports the adjustment, confirming its compliance with the management regulations and the incentive plan [6]

Core Viewpoint - The legal opinion letter from Beijing Zhonglun Law Firm addresses the adjustments to the grant price, the achievement of the vesting conditions for the third vesting period of the 2022 Restricted Stock Incentive Plan, and the cancellation of certain unvested restricted stocks for Jiangsu Tiannai Technology Co., Ltd. [1][23] Summary by Sections Grant Price Adjustment - The grant price for the restricted stocks under the 2022 incentive plan has been adjusted from 23.24 CNY per share to approximately 23.09 CNY per share due to a cash dividend distribution plan approved at the 2024 annual general meeting [13][15]. - The adjustment method follows the formula: P = P0 - V, where P0 is the original grant price and V is the cash dividend per share [15]. Vesting Conditions Achievement - The third vesting period for the first grant of restricted stocks is set from August 4, 2025, to July 31, 2026 [16]. - The vesting conditions include the absence of negative audit opinions and the fulfillment of performance targets related to revenue growth and sales from overseas brand customers [19][23]. - The company achieved a revenue of approximately 1.45 billion CNY for 2024, reflecting a 9.71% increase compared to 2021, and a significant increase of 829.07% in sales from overseas brand customers [19]. Cancellation of Restricted Stocks - A total of 30,592 shares of restricted stocks that were granted but not vested will be canceled according to the provisions of the 2022 incentive plan [23]. - The cancellation is in compliance with the relevant regulations and the company's internal policies [23].

Group 1 - The company has not distributed cash dividends, issued bonus shares, or increased capital from reserves during the reporting period [3] - The company did not experience any changes in its controlling shareholder or actual controller during the reporting period [5] - The company has approved the cancellation of unvested restricted stock from the 2024 incentive plan and the expiration of reserved rights [5][6] Group 2 - The company held board meetings to review and approve the 2025 restricted stock incentive plan and its management measures [6] - The relevant proposals regarding the 2025 incentive plan were approved at the 2024 annual general meeting [6]

登录新浪财经APP 搜索【信披】查看更多考评等级 公司代码：688312 公司简称：燕麦科技 第一节 重要提示 1.1本半年度报告摘要来自半年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规 划，投资者应当到www.sse.com.cn网站仔细阅读半年度报告全文。 1.2重大风险提示 公司已在本报告中描述公司面临的风险，敬请查阅本报告第三节"管理层讨论与分析"中"五、风险因 素"相关内容，请投资者予以关注。 1.3本公司董事会及董事、高级管理人员保证半年度报告内容的真实性、准确性、完整性，不存在虚假 记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 1.4公司全体董事出席董事会会议。 1.5本半年度报告未经审计。 1.6董事会决议通过的本报告期利润分配预案或公积金转增股本预案 不适用 □适用 √不适用 第二节 公司基本情况 2.1公司简介 公司股票简况 ■ 公司存托凭证简况 □适用 √不适用 联系人和联系方式 ■ 2.2主要财务数据 1.7是否存在公司治理特殊安排等重要事项 单位：元 币种：人民币 ■ 2.3前10名股东持股情况表 单位: 股 ■ 2.4前十名境内存托凭证持有人情况表 □适 ...

Core Points - The company is proposing amendments to its articles of association, which require approval from the shareholders' meeting [1] - The board of directors has requested authorization from the shareholders' meeting for the management to handle the necessary registration procedures with the market supervision administration after the amendments are approved [1] Summary of Management System Changes - The company has revised and abolished certain management systems to enhance corporate governance and ensure compliance with updated laws and regulations [2] - Specific systems abolished include the "Interim Measures for the Approval and Supervision of Fund Utilization" and the "Specific Object Visit System," with relevant content integrated into the "Fund Management System" and "Investor Relations Management System" respectively [2] - The revised governance systems will be submitted for shareholder approval, while other systems will take effect immediately upon board approval [2] Documentation for Reference - The resolutions from the 19th meeting of the fifth board of directors and the 17th meeting of the fifth supervisory board are available for review [3]

Core Viewpoint - The company has approved several resolutions regarding its stock incentive plans and the management of idle raised funds, ensuring compliance with relevant laws and regulations while aiming to enhance fund utilization efficiency and shareholder returns [3][7][35]. Group 1: Stock Incentive Plans - The board approved the resolution to cancel 196,000 shares of unvested restricted stock from the 2022 incentive plan due to 12 participants no longer qualifying [40]. - The board confirmed that the conditions for the second vesting period of the 2022 restricted stock incentive plan and the first vesting period of the 2023 plan have been met, allowing 170,400 shares and 235,762 shares to vest for 33 and 27 eligible participants respectively [3][39]. - The board's decisions regarding the stock incentive plans comply with the Company Law, Securities Law, and relevant regulations, ensuring no harm to the company's or shareholders' interests [42]. Group 2: Management of Idle Funds - The board approved a resolution to confirm the use of temporarily idle raised funds for cash management, increasing the authorized amount from 30 million yuan to 60 million yuan [7][14]. - The company previously exceeded the authorized cash management limit by 26.5 million yuan, which has been rectified, and the board confirmed that this did not adversely affect the company's operations or investment projects [13][15]. - The cash management will involve investing in safe and liquid financial products, aiming to improve the efficiency and returns of idle funds while ensuring compliance with regulations [27][17]. Group 3: Financial Reporting and Compliance - The company has disclosed its fundraising and usage status in accordance with regulatory requirements, ensuring transparency and compliance with the relevant laws [34]. - The company has established a dedicated fund management system and signed tripartite supervision agreements to ensure proper management of raised funds [24][12]. - The company has committed to strengthening internal controls and training for personnel involved in fund management to prevent future discrepancies [15][17].

Group 1 - The company plans to reappoint Tianjian Accounting Firm (Special General Partnership) as the auditor for the year 2025, pending approval at the second extraordinary general meeting of shareholders in 2025 [2][10][11] - The audit fee for 2025 is set at RMB 770,000, which is a decrease from the previous year's fee [8] - Tianjian Accounting Firm has a good investor protection capability, with a cumulative risk fund and professional insurance compensation limit exceeding RMB 200 million as of the end of 2024 [3] Group 2 - The audit committee and board of directors have both approved the proposal to reappoint Tianjian Accounting Firm, citing its ability to perform audits diligently and independently [9][10] - The firm has faced administrative penalties and self-regulatory measures in the past three years, but these do not affect its ability to perform audits for the company [7] - The project partner and signing registered accountants have relevant experience, with the lead partner having signed or reviewed 12 audit reports in the last three years [4][6] Group 3 - The company has announced the cancellation of 234,360 restricted stock options from the 2023 incentive plan, due to various reasons including the departure of employees and failure to meet performance targets [32][37] - The company has adjusted the internal investment structure of certain fundraising projects without changing the investment content or total amount, ensuring no adverse impact on project implementation [43][46] - The company will hold a second extraordinary general meeting of shareholders on September 15, 2025, to discuss various proposals including the reappointment of the auditor [53][54]